Benjamin Li

发表

Real-World Therapy Management and Outcomes of First-Line Axitinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma in the United States

Y. Zakharia, A. Vlahiotis, R. Levin, 2022, Frontiers in Oncology.

Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer

H. Rugo, A. DeMichele, G. Curigliano, 2022, npj Breast Cancer.

Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan

Y. Yatabe, K. Nishio, K. Togo, 2020, JTO clinical and research reports.

Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice

A. Brufsky, R. Layman, Xianchen Liu, 2021, Targeted Oncology.

Psychosocial Wellbeing among Patients with Breast Cancer during COVID-19

S. Kurosky, M. Maculaitis, Xianchen Liu, 2023, Current oncology.

Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data

S. Kohsaka, J. Mardekian, Y. Terayama, 2020, Open Heart.

Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer

H. Rugo, A. Brufsky, R. Layman, 2023, Breast.

Economic and Humanistic Burden Associated with Depression and Anxiety Among Adults with Non-Communicable Chronic Diseases (NCCDs) in the United States

R. McIntyre, J. Stephens, G. Poorman, 2021, Journal of multidisciplinary healthcare.

Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer

J. Rassen, S. Schneeweiss, N. Robert, 2023, Targeted Oncology.

Finite Mixture Models, a Flexible Alternative to Standard Modeling Techniques for Extrapolated Mean Survival Times Needed for Cost-Effectiveness Analyses.

Demissie Alemayehu, Birol Emir, Paul R Cislo, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer

H. Rugo, A. Brufsky, R. Layman, 2023, The oncologist.

Palbociclib Combined with an Aromatase Inhibitor in Patients with Breast Cancer with Lung or Liver Metastases in US Clinical Practice

H. Rugo, R. Layman, Xianchen Liu, 2023, Cancers.

Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older

H. Rugo, A. Brufsky, R. Layman, 2023, Frontiers in oncology.

Real‐world treatment patterns for palbociclib plus an aromatase inhibitor, or an aromatase inhibitor alone, for patients with metastatic breast cancer in the Flatiron Database

H. Rugo, R. Layman, Xianchen Liu, 2023, International journal of cancer.